scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | MacLennan A | |
P433 | issue | 7216 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebral palsy | Q210427 |
P304 | page(s) | 1054-1059 | |
P577 | publication date | 1999-10-01 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement | |
P478 | volume | 319 |
Q36587031 | 4D Ultrasound - Medical Devices for Recent Advances on the Etiology of Cerebral Palsy |
Q51171634 | A 'no-fault' cerebral palsy pension scheme would benefit all Australians. |
Q41528807 | A Controversial Medicolegal Issue: Timing the Onset of Perinatal Hypoxic-Ischemic Brain Injury. |
Q33871322 | A Systematic Review and Meta-analysis of the Timing of Early Intraventricular Hemorrhage in Preterm Neonates: Clinical and Research Implications |
Q42357223 | A cohort study of low Apgar scores and cognitive outcomes |
Q47150119 | A half century of electronic fetal monitoring and bioethics: silence speaks louder than words |
Q44770184 | A nationwide descriptive study of obstetric claims for compensation in Norway |
Q33692150 | A new tool for the validation of umbilical cord acid-base data |
Q24202191 | Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy |
Q24242942 | Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy |
Q24243672 | Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy |
Q91741112 | Altered Motoneuron Properties Contribute to Motor Deficits in a Rabbit Hypoxia-Ischemia Model of Cerebral Palsy |
Q40711154 | Analysis of antenatal-onset cerebral palsy secondary to transient ischemia in utero using a national database in Japan. |
Q33942848 | Analysis of cord blood gas at delivery: questionnaire study of practice in the United Kingdom |
Q48421197 | Anatomic localization of dyskinesia in children with "profound" perinatal hypoxic-ischemic injury |
Q57670308 | Antenatal and intrapartum antecedents of cerebral palsy: a case-control study |
Q47996134 | Antenatal risk factors associated with unfavorable neurologic status in newborns and at 2 years of age. |
Q31156454 | Asphyxia in the Newborn: Evaluating the Accuracy of ICD Coding, Clinical Diagnosis and Reimbursement: Observational Study at a Swiss Tertiary Care Center on Routinely Collected Health Data from 2012-2015. |
Q43872675 | Association between umbilical cord artery pCO₂ and the Apgar score; elevated levels of pCO₂ may be beneficial for neonatal vitality after moderate acidemia |
Q57783059 | Association of Moderate Alcohol Use and Binge Drinking During Pregnancy with Neonatal Health |
Q42149815 | Association of cerebral palsy with Apgar score in low and normal birthweight infants: population based cohort study |
Q46495222 | Attitudes and barriers to the introduction of umbilical cord blood gas and lactate analysis at birth |
Q42935014 | Benefits of introducing universal umbilical cord blood gas and lactate analysis into an obstetric unit |
Q33803575 | Birth events and cerebral palsy: facts were not presented clearly |
Q28074809 | Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy |
Q58770190 | Can Obstetric Risk Factors Predict Fetal Acidaemia at Birth? A Retrospective Case-Control Study |
Q24203662 | Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing |
Q24236707 | Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing |
Q24239964 | Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing |
Q24245548 | Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing |
Q38765500 | Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing |
Q42873503 | Cerebral Palsy and Alcohol Consumption during Pregnancy: Is There a Connection? |
Q30699869 | Cerebral palsy |
Q34619631 | Cerebral palsy and anaesthesia |
Q37187760 | Cerebral palsy in term infants: a clinicopathologic analysis of 158 medicolegal case reviews |
Q24537535 | Cerebral palsy--medicolegal aspects |
Q36307187 | Cerebral palsy-definition, classification, etiology and early diagnosis |
Q45787506 | Cerebral venous sinus thrombosis in a pre-term neonate diagnosed by MR-venography |
Q48541403 | Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain |
Q38163042 | Claims for compensation after alleged birth asphyxia: a nationwide study covering 15 years |
Q34131952 | Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study |
Q46525595 | Comparing fetal scalp lactate and umbilical cord arterial blood gas values |
Q50457385 | Congenital hemiplegia. A disease with manifold problems |
Q33262143 | Cord and placenta arterial gas analysis: the accuracy of delayed sampling |
Q47183290 | Correlation of hematocrit and Apgar scores in newborns of women with hypertensive disorders in pregnancy. |
Q44142396 | Crash emergency cesarean section: decision-to-delivery interval under 30 min and its effect on Apgar and umbilical artery pH. |
Q27006952 | Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy |
Q48317248 | Defining the True Pathogenesis and Pathophysiology of Neonatal Encephalopathy and Cerebral Palsy |
Q34781741 | Determination of pH or lactate in fetal scalp blood in management of intrapartum fetal distress: randomised controlled multicentre trial |
Q24605605 | Diagnosis, treatment, and prevention of cerebral palsy |
Q28360357 | Differential changes in insulin-like growth factors and their binding proteins following asphyxia in the preterm fetal sheep |
Q45229933 | Diffusion-weighted imaging and proton magnetic resonance spectroscopy in perinatal hypoxic-ischemic encephalopathy: association with neuromotor outcome at 18 months of age. |
Q47858442 | Does training in obstetric emergencies improve neonatal outcome? |
Q30838912 | Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia |
Q30245233 | Drivers of maternity care in high-income countries: can health systems support woman-centred care? |
Q48233576 | Dyskinetic cerebral palsy: a population-based study of children born between 1991 and 1998. |
Q38268070 | Dystonia in children and adolescents: a systematic review and a new diagnostic algorithm. |
Q46107036 | Edaravone inhibits DNA peroxidation and neuronal cell death in neonatal hypoxic-ischemic encephalopathy model rat. |
Q86359814 | Electronic Fetal Monitoring: A Defense Lawyer's View |
Q48147730 | Ephedrine for spinal hypotension during elective caesarean section: the final nail in the coffin? |
Q33800820 | Establishing probable cause in cerebral palsy. How much certainty is enough? |
Q51816111 | Ethical perspectives in cooling for term infants with intrapartum asphyxia. |
Q39456341 | Etiologic yield of cerebral palsy: a contemporary case series |
Q35574905 | Etiology of cerebral palsy |
Q35848941 | Evaluation of a child with cerebral palsy |
Q43066231 | Evaluation of cerebral function in high risk term infants by using a scoring system based on aEEG. |
Q43588688 | Evaluation of selection criteria for validating paired umbilical cord blood gas samples: an observational study |
Q35040107 | Experimental modelling of the consequences of brief late gestation asphyxia on newborn lamb behaviour and brain structure |
Q51698538 | FIGO consensus guidelines on intrapartum fetal monitoring: Physiology of fetal oxygenation and the main goals of intrapartum fetal monitoring. |
Q50473369 | Fetal heart rate pattern interpretation in the second stage of labor using the five-tier classification: impact of the degree and duration on severe fetal acidosis |
Q35001303 | Fetal hypoxia insults and patterns of brain injury: insights from animal models |
Q24193160 | Fetal pulse oximetry for fetal assessment in labour |
Q24245362 | Fetal pulse oximetry for fetal assessment in labour |
Q24246205 | Fetal pulse oximetry for fetal assessment in labour |
Q37118157 | Five-minute Apgar score ≤ 5 and Molar Incisor Hypomineralisation (MIH) - a case control study |
Q47760633 | From "apparent death" to "birth asphyxia": a history of blame |
Q47839544 | Gathering the evidence: cord gases and placental histology for births with low Apgar scores |
Q35810334 | Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies |
Q64111561 | Genetic or Other Causation Should Not Change the Clinical Diagnosis of Cerebral Palsy |
Q43609143 | How does the duration of active pushing in labor affect neonatal outcomes? |
Q42045648 | How long does it take to deliver a baby by emergency Caesarean section? |
Q36410770 | Hyperbaric oxygen in the treatment of patients with cerebral stroke, brain trauma, and neurologic disease |
Q48326715 | Impairment of fetal growth potential and neonatal encephalopathy |
Q35550965 | Interval between decision and delivery by caesarean section-are current standards achievable? Observational case series |
Q43791621 | Intrapartum fetal heart rate monitoring: evaluation of a standardized system of interpretation for prediction of metabolic acidosis at delivery and neonatal neurological morbidity |
Q24188081 | Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace |
Q24236752 | Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace |
Q24244623 | Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace |
Q27000167 | Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. |
Q36153611 | Investigation of global developmental delay |
Q73858238 | Is it time to abandon cardiotocographic ECG analysis? |
Q46141661 | Is oxygen therapy truly useful and necessary during elective cesarean section under spinal anesthesia? |
Q45237950 | Lactate dehydrogenase in hypothermia-treated newborn infants with hypoxic-ischaemic encephalopathy |
Q47331517 | Lame from birth: early concepts of cerebral palsy |
Q36193184 | Linking families and facilities for care at birth: what works to avert intrapartum-related deaths? |
Q35035694 | Long-lasting changes in DNA methylation following short-term hypoxic exposure in primary hippocampal neuronal cultures |
Q24676680 | Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review |
Q34456384 | Long-term developmental outcome of asphyxiated term neonates |
Q30882894 | MRI of Neonatal Encephalopathy |
Q24200779 | Magnesium sulphate for women at term for neuroprotection of the fetus |
Q24234006 | Magnesium sulphate for women at term for neuroprotection of the fetus |
Q33513727 | Mary Crosse project: systematic reviews and grading the value of neonatal tests in predicting long term outcomes |
Q50944240 | Maternal and neonatal outcome after failed ventouse delivery: comparison of forceps versus cesarean section. |
Q36937939 | Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia |
Q41834648 | Multiorgan dysfunction in infants with post-asphyxial hypoxic-ischaemic encephalopathy |
Q24247454 | Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia |
Q40374594 | Neonatal hypoxic-ischemic encephalopathy in apparently low risk pregnancies: retrospective analysis of the last five years at the University of Bologna |
Q46343443 | Neonatal organ dysfunction among newborns at gestational age 34 weeks and umbilical arterial pH<7.00. |
Q40176153 | Neonatal outcomes following a trial of labor after Caesarean delivery: a population-based study |
Q33875666 | Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: a systematic review, meta-analysis and Delphi estimation of mortality effect |
Q37611233 | Obstetric care in low-resource settings: what, who, and how to overcome challenges to scale up? |
Q48829884 | Obstetric parameters and Doppler findings in cerebral circulation as predictors of 1 year neurodevelopmental outcome in asphyxiated infants |
Q57009879 | Obstetric risk factors for poor neonatal adaptation at birth |
Q53080278 | Obstetrics at Decisive Crossroads Regarding Pattern-Recognition of Fetal Heart Rate Decelerations: Scientific Principles and Lessons From Memetics. |
Q35686055 | One-year neurodevelopmental outcome after moderate newborn hypoxic ischaemic encephalopathy |
Q42764633 | Only a minor part of cerebral palsy cases begin in labour. But still room for controversial childbirth issues in court |
Q30486614 | Open access intrapartum CTG database. |
Q48224132 | Parasympathetic tone variations according to umbilical cord pH at birth: a computerized fetal heart rate variability analysis. |
Q36117886 | Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes? |
Q44014212 | Perinatal and maternal outcome following abruptio placentae |
Q33446818 | Perinatal asphyxia |
Q41649113 | Perinatal infection and hypoxic-ischemic encephalopathy: a pilot study |
Q47435108 | Placental weight and placental weight to birthweight ratio in relation to Apgar score at birth: a population study of 522 360 singleton pregnancies |
Q34091662 | Potential biomarkers for hypoxic-ischemic encephalopathy |
Q51890251 | Predictors of outcome in term infants with neonatal seizures subsequent to intrapartum asphyxia. |
Q28077021 | Preterm Hypoxic-Ischemic Encephalopathy |
Q36104356 | Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy |
Q35296796 | Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study |
Q52045357 | Profile of pediatric hemiparesis. |
Q36445907 | Quantification of structural changes in the corpus callosumin children with profound hypoxic-ischaemic brain injury. |
Q33643447 | Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status |
Q37397669 | Rare copy number variation in cerebral palsy |
Q48399830 | Rationale for IL-1beta-targeted therapy to minimize hypoxic-ischemic encephalopathy |
Q36121422 | Recent trends in visual impairment and blindness in the UK. |
Q73953954 | Reducing risk by improving standards of intrapartum fetal care |
Q42905800 | Relation between umbilical cord blood pH, base deficit, lactate, 5‐minute Apgar score and development of hypoxic ischemic encephalopathy |
Q37207814 | Resuscitation at birth and cognition at 8 years of age: a cohort study |
Q33895991 | Risk of cerebral palsy among the offspring of immigrants |
Q41262656 | Role of Anesthesiologist in the Management of a Child with Cerebral Palsy |
Q37986091 | S100B - a potential biomarker for early detection of neonatal brain damage following asphyxia |
Q48579828 | S100B protein related neonatal hypoxia |
Q58173847 | STAN®-recorded intrapartum loss of beat-to-beat variation associated with prolonged QT-interval: Indicative for fetal hypocalcemia? |
Q26798406 | Scourge of intra-partum foetal death in Sub-Saharan Africa |
Q58784931 | Sensors for Fetal Hypoxia and Metabolic Acidosis: A Review |
Q33815960 | Setting research priorities to reduce almost one million deaths from birth asphyxia by 2015 |
Q36477455 | Severe asphyxia due to delivery-related malpractice in Sweden 1990-2005. |
Q35642543 | Severe fetal acidemia in cases of clinical chorioamnionitis in which the infant later developed cerebral palsy |
Q37219833 | Snoring during pregnancy and delivery outcomes: a cohort study |
Q33577720 | Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis |
Q50653819 | Suboptimal care and metabolic acidemia is associated with neonatal encephalopathy but not with neonatal seizures alone: a population-based clinical audit. |
Q49719878 | Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs. |
Q37787587 | The 30minute decision to delivery time is unrealistic in morbidly obese women |
Q38612782 | The Change of Perinatal Mortality in Three Decades in a Reference Center in Aegean Region: Neonatal Mortality has Decreased but Fetal Mortality Stayed Unchanged |
Q35295423 | The Scottish perinatal neuropathology study: clinicopathological correlation in early neonatal deaths |
Q52942220 | The association of nuchal cord with cerebral palsy is influenced by recording bias. |
Q35201430 | The biological basis of injury and neuroprotection in the fetal and neonatal brain |
Q53577169 | The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998. |
Q50625909 | The consistency of experts' evaluation of obstetric claims for compensation. |
Q44560764 | The effects of asphyxia on renal function in fetal sheep at midgestation |
Q35071364 | The epidemiology and causes of cerebral palsy |
Q39064570 | The genetic basis of cerebral palsy |
Q54792425 | The impact of introducing universal umbilical cord blood gas analysis and lactate measurement at delivery. |
Q45919545 | The incidence and implications of cerebral palsy following potentially avoidable obstetric complications: a preliminary burden of disease study. |
Q48605984 | The influence of maternal epidural analgesia upon intrapartum fetal oxygenation |
Q34268363 | The pediatric neurologist as expert witness with particular reference to perinatal asphyxia. |
Q45017506 | The relationship between umbilical cord arterial pH and serious adverse neonatal outcome: analysis of 51,519 consecutive validated samples |
Q83322775 | The role of perinatal and intrapartum risk factors in the etiology of cerebral palsy in term deliveries in a Turkish population |
Q33280308 | Theory of obstetrics: an epidemiologic framework for justifying medically indicated early delivery. |
Q37611232 | Two million intrapartum-related stillbirths and neonatal deaths: where, why, and what can be done? |
Q48314216 | Two-year follow-up study on neurodevelopmental outcomes after term intrapartum asphyxia using age and stages questionnaire |
Q57239412 | Two-year outcomes for infants with low cord pH at birth |
Q35480339 | Umbilical arterial blood gas and perinatal outcome in the second twin according to the planned mode of delivery |
Q34977208 | Update of the Amiel-Tison neurologic assessment for the term neonate or at 40 weeks corrected age. |
Q37756239 | Using malpractice claims to identify risk factors for neurological impairment among infants following non-reassuring fetal heart rate patterns during labour. |
Q35296590 | Why is there a modifying effect of gestational age on risk factors for cerebral palsy? |
Q53644826 | [EEG and ischemic stroke in full-term newborns] |
Q39275555 | pH, base deficit or lactate. Which is better for predicting neonatal morbidity? |
Search more.